EurekAlert! -
23 Mar 2020 06:00
(Mary Ann Liebert, Inc./Genetic Engineering News) A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain.
Share this Article